107 related articles for article (PubMed ID: 8140040)
1. An organic acid-induced sigmoidal release system for oral controlled-release preparations.
Narisawa S; Nagata M; Danyoshi C; Yoshino H; Murata K; Hirakawa Y; Noda K
Pharm Res; 1994 Jan; 11(1):111-6. PubMed ID: 8140040
[TBL] [Abstract][Full Text] [Related]
2. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
[TBL] [Abstract][Full Text] [Related]
4. [Drug release mechanism of famotidine time-controlled release pellets].
Zhang L; Chen DW; Gao ZB
Yao Xue Xue Bao; 2006 Sep; 41(9):873-7. PubMed ID: 17111836
[TBL] [Abstract][Full Text] [Related]
5. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
[TBL] [Abstract][Full Text] [Related]
6. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
7. Influence of hydroxyethylcellulose on the drug release properties of theophylline pellets coated with Eudragit RS 30 D.
Zheng W; Sauer D; McGinity JW
Eur J Pharm Biopharm; 2005 Jan; 59(1):147-54. PubMed ID: 15567312
[TBL] [Abstract][Full Text] [Related]
8. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
9. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
[TBL] [Abstract][Full Text] [Related]
10. [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].
Orugun O; Oyi A; Olowosulu A; Apeji Y; Olayemi O
Ceska Slov Farm; 2016; 65(6):226-231. PubMed ID: 28079388
[TBL] [Abstract][Full Text] [Related]
11. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs.
Ikegami K; Tagawa K; Osawa T
J Pharm Sci; 2006 Sep; 95(9):1888-95. PubMed ID: 16850398
[TBL] [Abstract][Full Text] [Related]
13. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
14. Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES).
Yang L; Watanabe S; Li J; Chu JS; Katsuma M; Yokohama S; Fix JA
Pharm Res; 2003 Mar; 20(3):429-34. PubMed ID: 12669964
[TBL] [Abstract][Full Text] [Related]
15. A novel pulsatile drug delivery system based on the physiochemical reaction between acrylic copolymer and organic acid: in vitro and in vivo evaluation.
Zhang Z; Qi X; Li X; Xing J; Zhu X; Wu Z
Int J Pharm; 2014 Feb; 462(1-2):66-73. PubMed ID: 24368107
[TBL] [Abstract][Full Text] [Related]
16. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
[TBL] [Abstract][Full Text] [Related]
17. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
Cantor SL; Hoag SW; Augsburger LL
Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
[TBL] [Abstract][Full Text] [Related]
19. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
20. Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.
Wulff R; Leopold CS
Int J Pharm; 2014 Dec; 476(1-2):78-87. PubMed ID: 25239771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
